Piriformis Syndrome: What the Evidence Actually Shows

Key Takeaways: Piriformis Syndrome

• Piriformis syndrome describes buttock pain and sciatica-type symptoms attributed to irritation or compression of the sciatic nerve near the piriformis muscle, but its symptoms overlap with several lumbar, hip, sacroiliac, and deep-gluteal conditions.
• Published prevalence estimates vary from under 1% to over 40%, largely because studies use different populations, sampling methods, and diagnostic criteria. There is still no validated diagnostic gold standard.
• A positive anatomical variant, MRI finding, or bedside test does not confirm that the piriformis muscle is causing the pain. Conversely, many published cases have no identified structural abnormality.
• The often-cited FAIR-test sensitivity and specificity figures apply to an electrophysiological H-reflex protocol, not simply to the ordinary bedside pain-provocation maneuver.
• Combining the active piriformis and seated piriformis stretch tests may be more informative than relying on either alone, but the supporting study involved only 33 selected surgical patients.
• MRI and ENMG may help identify alternative explanations such as lumbar radiculopathy or sciatic neuropathy, but neither can independently confirm piriformis syndrome.
• Physiotherapy and other conservative approaches generally form the starting point. Evidence does not establish one stretching, strengthening, manual-therapy, or other conservative protocol as clearly superior.
• Injections, botulinum toxin, and shockwave therapy have been associated with improvement, but the studies are small or heterogeneous, and the contribution of placebo and other contextual effects remains uncertain.
• Surgery is described in the international literature but appears to have a highly selected role and is far removed from ordinary clinical management.
• Piriformis syndrome is best treated as a cautious clinical possibility within a broader differential diagnosis—not as an automatic explanation for every case of buttock pain or a presumed “tight piriformis.”

Introduction: Piriformis Syndrome

Piriformis syndrome is generally used to describe buttock pain and sciatica-type symptoms attributed to irritation or compression of the sciatic nerve in the region of the piriformis muscle. The pain is typically felt deep in the buttock, may radiate into the posterior thigh or further down the leg, and is often aggravated by sitting [8][15]. These features are not specific to piriformis syndrome, however, and can overlap with several lumbar, hip, sacroiliac, and other deep-gluteal conditions.

This helps explain why piriformis syndrome remains one of the most inconsistently diagnosed conditions in sports and musculoskeletal medicine. Reported prevalence among patients with sciatica-type symptoms ranges from under 1% in some orthopedic literature reviews to over 40% in cohorts that actively screen for it, with estimates varying substantially according to the diagnostic criteria, study population, and sampling methods used [1][3][4][6]. That is not a rounding error—it reflects a field that still lacks a validated reference standard for diagnosis.

Buttock-region pain is also a common reason for seeking clinical assessment. In my own practice, I encounter it frequently among office workers, often in the context of prolonged sitting or standing. The same region can become symptomatic in physically active people, including cyclists and those whose gym training repeatedly loads the hips and gluteal area. Yet the diagnostic label applied to these symptoms varies considerably. One clinician may attribute them to sacroiliac joint dysfunction, another to lumbar radiculopathy or sciatica, and another to piriformis syndrome.

These labels are not interchangeable, even though the symptoms may overlap. A runner, lifter, desk-bound office worker, or coach may hear a confident explanation involving a “tight piriformis” when the clinical picture is considerably less certain. This article examines what systematic reviews, diagnostic-accuracy studies, and randomized trials actually show, separating what is reasonably supported from what is often repeated out of habit.

How Common Is Piriformis Syndrome, Really?

The honest answer is that nobody knows precisely, and the range of published estimates makes that clear. Piriformis syndrome has been estimated to account for as little as 0.3% and as much as 6% of all low back pain and sciatica cases in some analyses [6], while a separate review put the range as wide as 0.3% to 36% of patients with radiating low back pain [5]. A 2024 Turkish cohort study that deliberately screened for piriformis syndrome before assuming a discogenic cause found a prevalence of 40.9% among sciatica patients — well above most of the existing literature [4]. Most recently, a 2026 global systematic review and meta-analysis pooled published prevalence data and arrived at an overall estimate of 46.79% (95% CI: 34.7–58.8%), with the highest pooled estimates coming from Asian cohorts [3].

This roughly hundredfold spread across studies is itself a finding. It reflects inconsistent diagnostic criteria, small and heterogeneous samples, and a strong dependence on whether a study actively looked for the condition or diagnosed it only after ruling out disc pathology. The condition is also reported to affect women disproportionately, with some sources citing a female-to-male ratio as high as 6:1, most commonly presenting in middle age [6].

The situation becomes even more complicated when lumbar MRI shows a disc protrusion or herniation. An imaging finding may be relevant, but its presence alone does not establish that it is responsible for the patient’s buttock or leg symptoms. The radiological finding still has to fit the clinical pattern.

In my experience, the interpretation can also be influenced by the clinician’s perspective. A spine-focused specialist may naturally give greater weight to a disc abnormality, whereas another clinician may be more inclined to interpret the same presentation as piriformis-related pain. I would not reduce this to a simple difference between specialties, but it illustrates how the same symptoms and imaging findings can lead to different conclusions.

In practice, diagnosing piriformis syndrome is therefore often less about confirming one definitive finding and more about assessing whether the overall presentation is compatible with the diagnosis while considering and excluding other plausible explanations. That is a less satisfying answer than pointing to a single structure on an MRI scan, but it is often a more honest description of the diagnostic process.

What’s Actually Happening Anatomically in Piriformis Syndrome

Piriformis syndrome is generally described as sciatic nerve compression or irritation caused by the piriformis muscle in the deep gluteal region — an area increasingly referred to in the more recent literature as “deep gluteal syndrome,” a broader term that also captures other soft-tissue sources of sciatic-type pain in that space [15].

One long-standing theory has centered on anatomical variants — cases where the sciatic nerve passes through or around the piriformis muscle rather than beneath it. A systematic review and meta-analysis of cadaveric and imaging studies found that the typical, unremarkable nerve-muscle relationship (Type A) had a pooled prevalence of 90%, while all anatomical variants combined were pooled at only 13% [7]. Because these variants are documented in anatomical studies of unselected populations rather than in studies comparing symptomatic and asymptomatic people, identifying a variant in a given patient does not by itself establish that the variant is causing their pain.

From a clinical perspective, these anatomical variants are interesting, but their day-to-day diagnostic value is limited. In most consultations, I do not have reliable information about the precise course of the patient’s sciatic nerve relative to the piriformis muscle. Unless a relevant variant has been demonstrated through appropriate imaging or during surgery, it remains a theoretical possibility rather than a finding that can meaningfully explain the symptoms. The published case literature also shows that piriformis syndrome is frequently diagnosed without an identified anatomical variant: in a 2025 review, such a variant was reported in only 12.7% of cases, while 47.6% had no instrumental or intraoperative finding at all [2]. This does not prove that every clinically diagnosed case represents true piriformis-related nerve compression, but it does show that an anatomical variant is not a necessary feature of cases reported under this diagnosis. For that reason, I would not allow anatomical speculation to carry more weight than the history, examination, and broader differential diagnosis.

The same 2025 systematic review included 212 published cases of piriformis syndrome. In addition to the 12.7% with an anatomical variant, piriformis muscle hypertrophy was identified in 7.5%, and approximately half of the cases were diagnosed clinically from symptoms, history, and physical examination rather than from an identified structural cause [2]. The review also found a female-to-male ratio of approximately 1.2:1—substantially less marked than the 6:1 ratio sometimes cited elsewhere. This is another reminder that reported anatomical and demographic patterns can shift considerably depending on which patient population is being examined.

Assessing Piriformis Syndrome: How Reliable Is the Diagnosis?

This is where the evidence is weakest, and where clinicians should be most cautious about overconfidence.

The most widely cited clinical test is the FAIR test (flexion, adduction, internal rotation), which reproduces symptoms by stretching the piriformis over the sciatic nerve. Its diagnostic performance numbers trace back to a large 10-year cohort study of 918 patients, which reported sensitivity of 0.881 and specificity of 0.832 [9]. It’s important to be precise about what those figures describe: they apply to an electrophysiological FAIR protocol measuring H-reflex latency, not simply to the bedside pain-reproduction maneuver commonly called the FAIR test. The electrophysiological test was assessed against a separate clinical “working definition” of piriformis syndrome rather than an independent, validated diagnostic gold standard, which limits how far the reported sensitivity and specificity can be generalized to ordinary clinical use of the test.

A separate diagnostic-accuracy study compared clinical tests against endoscopically confirmed sciatic nerve entrapment in 33 patients and found that combining the active piriformis test with the seated piriformis stretch test produced sensitivity of 91% and specificity of 80%, notably better than either test alone [10]. This supports a broader principle in the literature: no single clinical sign should be relied on in isolation.

Imaging doesn’t resolve the uncertainty either. In the 2025 case-series review mentioned above, intrapelvic MRI or MR neurography was reported as corroborating the diagnosis before treatment in 29.7% of cases, while 50.5% had been diagnosed clinically [2]. Ultrasound-based measurement of piriformis muscle thickness has also been studied as a possible diagnostic aid in a case-control design comparing symptomatic and asymptomatic individuals, though this remains an emerging approach rather than an established standard [11].

An updated systematic review of the clinical-features literature, published as a follow-up to the original 2010 review, was candid about these limitations: it concluded that the most commonly reported features were buttock pain, pain aggravated by sitting, tenderness near the greater sciatic notch, and pain on maneuvers that stretch the piriformis, but that study quality had not meaningfully improved since 2010, with considerable under-reporting of negative findings and a high risk of bias in the largest cross-sectional studies available [8].

Piriformis-type symptoms can overlap considerably with those attributed to a lumbar disc herniation. An MRI finding alone may not settle the question unless the clinical and radiological picture is particularly clear. In practice, I sometimes see ENMG used to look for objective evidence of nerve-root involvement when the significance of a disc finding remains uncertain. When the clinical presentation, MRI level, and electrodiagnostic findings are anatomically concordant, the combined picture can make a disc-related radiculopathy more likely.

This is different from using ENMG to confirm piriformis syndrome. A normal result does not rule out piriformis-related or deep gluteal pain, particularly when symptoms are predominantly painful, intermittent, or position-dependent. Its main value in this setting is therefore often exclusionary: it may identify evidence supporting radiculopathy or a more peripheral sciatic neuropathy, but it does not establish that the piriformis muscle is the source of the symptoms.

Evidence-Based Solutions for Piriformis Syndrome

Given the diagnostic uncertainty, it’s worth being similarly precise about what the treatment literature does and doesn’t establish.

Injections. A double-blinded randomized controlled trial compared local anesthetic alone against local anesthetic plus corticosteroid, injected under ultrasound guidance into the piriformis muscle in 47 patients who had responded to a diagnostic injection. Both groups showed statistically significant reductions in pain from baseline at one week, one month, and three months, but there was no significant difference between the two groups at any time point — meaning the corticosteroid added no measurable benefit over local anesthetic alone [13]. That’s a useful, cost- and risk-relevant finding on its own — but it’s worth being precise about what the trial can and can’t tell us: it didn’t include a no-injection or placebo-injection arm, so it can’t isolate how much of the improvement came from the anesthetic itself versus the needle, the ultrasound-guided placement, or the natural course of the condition.

At our clinic, we occasionally use an injection combining a corticosteroid with bupivacaine, and some patients have reported subjective pain relief following the procedure. However, because the trial did not include a placebo-injection or no-injection group, we do not know how much placebo and other contextual effects contributed to the improvement observed in either the study or clinical practice.

Botulinum toxin. A systematic review pooling three randomized controlled trials, two case-control studies, and two cohort studies (152 patients total) concluded there is fair-quality evidence that botulinum toxin A is safe and reduces pain in piriformis syndrome, with doses in the studies ranging from 100 to 300 units. However, the review was explicit that the included studies were too heterogeneous to quantify the actual size of the pain reduction, and functional outcomes were poorly reported across the literature [12].

Shockwave therapy versus corticosteroid injection. A randomized clinical trial comparing radial extracorporeal shockwave therapy against ultrasound-guided corticosteroid injection found that both treatments produced significant improvements in pain and quality of life, with no significant difference between the groups by the final follow-up. The shockwave group did show a faster onset of pain reduction, appearing by one week, compared with the corticosteroid group [14].

Conservative and manual therapies. Stretching, manual therapy, dry needling, myofascial release, and hip-strengthening programmes, which may use isometric, concentric, eccentric, or combined dynamic loading— are all commonly used in practice. A systematic review of conservative and surgical treatments for deep gluteal syndrome found that while both approaches are recommended as primary management, evidence supporting the superiority of one treatment over another is lacking [16]. That makes it difficult to say which conservative components actually help, or how they compare with the injection-based treatments above — a genuine evidence gap rather than a reason to avoid trying them.

In practice, management generally begins with physiotherapy and other conservative measures. If symptoms remain persistent and the diagnosis is still considered plausible, an injection may sometimes be considered. This is also broadly how I approach these cases clinically: treatment is usually escalated gradually rather than moving directly to an invasive intervention.

Surgery is a very different matter. Although procedures such as sciatic nerve decompression, neurolysis, and piriformis tendon release are described in the international literature, they appear to occupy a highly selected role. In my own clinical experience in Finland, I have not encountered a patient undergoing surgery specifically for piriformis syndrome. That observation cannot establish how frequently these procedures are performed nationally, but it does illustrate how far surgical treatment is from ordinary clinical management in my setting.

Conclusion: What the Evidence on Piriformis Syndrome Actually Shows

Piriformis syndrome remains a plausible explanation for some cases of buttock and sciatica-type pain, but it is not a diagnosis that can be confirmed confidently from one symptom, bedside test, imaging finding, or anatomical variant. Its typical features overlap with lumbar radiculopathy, sacroiliac and hip-related pain, and other causes of deep gluteal syndrome. MRI and ENMG may help identify competing explanations, but neither can establish that the piriformis muscle is the source of the symptoms. In practice, the diagnosis therefore rests on the overall clinical pattern and the careful consideration of alternatives rather than on a single definitive finding.

The treatment evidence is similarly uncertain. Physiotherapy and other conservative approaches generally form the starting point, while injections may be considered in selected persistent cases. Local anesthetic, corticosteroid, botulinum toxin, and shockwave therapy have all been associated with improvement in small or heterogeneous studies, but their comparative effectiveness—and the contribution of placebo, contextual effects, and natural symptom fluctuation—remains difficult to determine. Surgery is described in the literature but appears far removed from routine clinical management, at least in my own experience in Finland. The most defensible conclusion is therefore not that piriformis syndrome is either a myth or an easily identifiable structural disorder, but that it is a clinically useful yet uncertain diagnostic possibility that warrants cautious interpretation, a broad differential diagnosis, and proportionate management.

References

1. https://pubmed.ncbi.nlm.nih.gov/20596735/
2. https://bmcsurg.biomedcentral.com/articles/10.1186/s12893-025-03202-2
3. https://www.sciencedirect.com/science/article/pii/S2214751926001039
4. https://pmc.ncbi.nlm.nih.gov/articles/PMC11452884/
5. https://link.springer.com/chapter/10.1007/978-3-031-40736-9_15
6. https://www.ncbi.nlm.nih.gov/books/NBK448172/
7. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7746330/
8. https://pubmed.ncbi.nlm.nih.gov/28836092/
9. https://pubmed.ncbi.nlm.nih.gov/11887107/
10. https://link.springer.com/article/10.1007/s00167-013-2758-7
11. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8453065/
12. https://pubmed.ncbi.nlm.nih.gov/35865325/
13. https://pubmed.ncbi.nlm.nih.gov/25794202/
14. https://pubmed.ncbi.nlm.nih.gov/36775517/
15. https://pubmed.ncbi.nlm.nih.gov/31558515/
16. https://pubmed.ncbi.nlm.nih.gov/37949567/